Press release
Transmucosal Drug Delivery Devices Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts
Transmucosal Drug Delivery Devices
What Is the Expected Transmucosal Drug Delivery Devices Market Size During the Forecast Period?
The transmucosal drug delivery devices market has experienced strong growth in recent years. It will grow from $50.24 billion in 2024 to $55.04 billion in 2025 at a CAGR of 9.6%. The growth is fueled by the need for rapid relief from angina, the effectiveness of sublingual delivery for quick absorption, the desire to bypass gastrointestinal degradation, the development of buccal tablets, and the need for non-invasive delivery of peptides and proteins.
The transmucosal drug delivery devices market is projected to grow substantially, reaching $78.21 billion by 2029, with a CAGR of 9.2%. The growth is attributed to the development of smart drug delivery systems, the rising prevalence of chronic diseases, the growing focus on personalized medicine, an aging population with higher medication needs, and increased awareness of treatment options. Key trends in the forecast period include expanding therapeutic applications, customizing devices for personalized medicine, regulatory approvals, eco-friendly devices, and innovative drug formulations.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16812
What Are the High-Growth Segments in the Transmucosal Drug Delivery Devices Market?
The transmucosal drug delivery devices market covered in this report is segmented -
1) By Type: Passive Transdermal Drug Delivery, Active Transdermal Drug Delivery
2) By Drug Type: Buccal Tablets, Oral Sprays, Sublingual Films And Wafers, Gels, Medicated Confectionery, Other Drug Types
3) By Indication: Pain Management, Addiction Treatment, Hormonal Therapies, Others Indications
4) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Hospitals
Subsegments:
1) By Passive Transdermal Drug Delivery: Reservoir Systems, Matrix Systems, Micro-Needle Systems, Pressure-Sensitive Adhesive Systems
2) By Active Transdermal Drug Delivery: Iontophoresis, Sonophoresis, Electroporation, Thermal Ablation, Microporation
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16812&type=smp
What Key Drivers Are Expected to Influence Future Transmucosal Drug Delivery Devices Market Growth?
The rising prevalence of chronic diseases is expected to drive the growth of the transmucosal drug delivery devices market. Chronic conditions require long-term management, and transmucosal drug delivery devices ensure efficient, controlled medication delivery for these conditions. The growing number of chronic disease diagnoses is increasing the need for such devices. For example, the Leukemia & Lymphoma Society (LLS) projected 184,720 new leukemia, lymphoma, and myeloma cases in the US in 2023, fueling the demand for these devices.
Which Companies Hold the Largest Share Across Different Transmucosal Drug Delivery Devices Market Segments?
Major companies operating in the transmucosal drug delivery devices market are Johnson & Johnson, Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, Becton Dickinson and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup, Glenmark Pharmaceuticals Limited, Stevanato Group S.p.A, Lifevision Healthcare Private Limited, Noven Pharmaceuticals, SAVA Healthcare Limited, Antares Pharma Inc., Kaizen Pharmaceuticals Pvt. Ltd., Lucky Pharma Pvt. Ltd., Maya Biotech Pvt. Ltd, AdvaCare Pharma LLP, Satsuma Pharmaceuticals Inc., Biophar Lifesciences Private Limited, Fibovil Pharmaceuticals Private Limited, Slan Medicinal Holdings Ltd.
What Trends Are Driving Growth in The Transmucosal Drug Delivery Devices Market?
In the transmucosal drug delivery devices market, companies are innovating with smart platforms like proprietary transdermal patch delivery technologies to improve drug absorption and enhance patient compliance. These platforms are designed to administer medications through the skin in a controlled manner, improving therapeutic results. For instance, in January 2024, Starton Therapeutics Inc., a US-based biotechnology firm, introduced STARSILON, a new proprietary transdermal patch delivery platform for prolonged therapeutic delivery of difficult-to-formulate active pharmaceutical ingredients (APIs). This platform expands the options for transdermal drug delivery, improving efficacy with sustained release.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/transmucosal-drug-delivery-devices-global-market-report
What Are the Emerging Geographies for The Transmucosal Drug Delivery Devices Market Growth?
North America was the largest region in the transmucosal drug delivery devices market in 2024. The regions covered in the transmucosal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Transmucosal Drug Delivery Devices Market?
2. What is the CAGR expected in the Transmucosal Drug Delivery Devices Market?
3. What Are the Key Innovations Transforming the Transmucosal Drug Delivery Devices Industry?
4. Which Region Is Leading the Transmucosal Drug Delivery Devices Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Transmucosal Drug Delivery Devices Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts here
News-ID: 4046109 • Views: …
More Releases from The Business Research Company
2025-2034 Mainframe Modernization Market Evolution: Emerging Opportunities and M …
What Is the Projected Size of the Mainframe Modernization Market by 2025?
Recent years have witnessed substantial expansion in the market dedicated to mainframe modernization, with projections indicating a climb from a valuation of $15.72 billion in 2024 up to $18.12 billion by 2025, a trajectory translating to a compound annual growth rate (CAGR) of 15.2%. This historical upward trend is fueled by several key factors, chief among them being escalating…
Accelerated Digital Transformation Fuels Expansion in the Liquid Crystal Polymer …
How Much Will the Liquid Crystal Polymer (LCP)-Based Molded Interconnect Device Market Size Increase by 2025?
The market for liquid crystal polymer (LCP)-based molded interconnect devices has experienced swift augmentation recently, projected to escalate from a value of $0.64 billion in 2024 to $0.75 billion in 2025, reflecting a compound annual growth rate (CAGR) of 17.3%. This historical expansion is largely traceable to several key factors, including the wider acceptance of…
Consistent Growth Projected for Land-Based Command, Control, Communications, Com …
How Much Is the Land-Based Command, Control, Communications, Computers, Intelligence, Surveillance, And Reconnaissance( C4ISR ) Market Expected to Expand by 2025?
The terrestrial C4ISR sector has experienced robust expansion lately, projected to increase its valuation from $32.64 billion in 2024 to $34.87 billion the following year, reflecting a steady compound annual growth rate of 6.8%. This upward trajectory in the past phase is traceable to several key factors, including a more…
Surging Application Across End Users Powers the Expansion of the Intelligent Ele …
How Large Is the Intelligent Electrical Panel Market Expected to Be by 2025?
The electrical panel segment characterized by intelligence has experienced swift expansion recently, projected to escalate its valuation from a total of $4.47 billion in the year 2024 to $4.95 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 10.7%; this upward trajectory throughout the preceding period is linked to several factors, namely the escalating need for…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
